| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. | J Med Chem | 2014 | 0.93 |
| 2 | Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis. | Antimicrob Agents Chemother | 2013 | 0.87 |
| 3 | 4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity. | J Med Chem | 2014 | 0.82 |
| 4 | N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds. | J Med Chem | 2014 | 0.82 |
| 5 | Pyrazolopyrimidines establish MurC as a vulnerable target in Pseudomonas aeruginosa and Escherichia coli. | ACS Chem Biol | 2014 | 0.77 |